"The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected ...

The global Lateral Flow Assay Components Market, valued at US$378.4 million in 2024, stood at US$392.4 million in 2025 and is ...

Clinical testing remained the leading application segment in 2024. The lateral flow assays market is expected to reach ...

Liquid crystals, the same technology found in TV screens, strip thermometers, and mood rings, could soon be used in the next ...

AUSTIN, Texas and TOKYO, Sept. 9, 2025 /PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected ...

York-based lateral flow test specialist Abingdon Health has revealed it has five new development projects under way in the US ...

The Canadian company is also working to increase utilization of its point-of-care infectious disease assays, such as tests for HIV and syphilis.

Further, the US held the majority share in the global lateral flow assays market and is likely to remain the leading region growing at a CAGR of 7.7% within this market, during the forecast period.

The US Food and Drug Administration issued marketing clearances for antimicrobial susceptibility tests, respiratory infection tests, and a cardiac troponin test, among others.

(Alliance News) - Abingdon Health PLC on Monday reported progress at Abingdon Health USA Inc, with five projects currently underway at its facilities in Madison, Wisconsin. Shares in the York, England ...

A coalition of industry and professional bodies has urged the government and NHS leaders to increase funding for in vitro ...